Background: Acute cholecystitis (AC) is a common differential for patients presenting to the emergency
Conclusion:
Variable disease prevalence, coupled with limited sample sizes, increases the risk of selection bias.
Individually, none of these investigations reliably rule out AC. Development of a clinical decision rule to include evaluation of H&P, laboratory data, and US are more likely to achieve a correct diagnosis of AC.
A bdominal pain is one of the most common chief complaints encountered by emergency department (ED) physicians. Many abdominal pain patients are found to have a benign etiology. However, the possibility of acute cholecystitis (AC), which accounts for 3%-11% of hospital admissions [1] [2] [3] with a mortality rate of 0.8%, 4 usually requires a comprehensive diagnostic evaluation using the modalities of history and physical examination (H&P), laboratory results, and imaging studies. Many studies have previously described individually the H&P, 5, 6 laboratory, 7, 8 and imaging 9, 10 consistent with AC. The Tokyo AC guidelines by Hirota et al. 11 utilized an expert consensus methodology to integrate multiple diagnostic modalities to predict AC. Hirota et al. l1 determined a definitive diagnosis of AC could be obtained if the patient exhibited at least one of the two local signs of inflammation (Murphy's sign or right upper quadrant [RUQ] mass/pain/tenderness) plus one of the systemic signs of inflammation (fever, elevated C-reactive protein or elevated while blood cell count [WBC] ). Then if AC was clinically suspected, a definitive diagnosis of AC would still depend on a radiology department study (ultrasound [US], computerized tomography [CT] , magnetic resonance imaging [MRI] , or hepatobiliary iminodiacetic acid scan/cholescintigraphy [HIDA] ). Recently an updated version of the Tokyo AC guidelines (TG13) 12 was validated in a similar population to the derivation cohort with a sensitivity of 87.6% and specificity of 77.7%.
Although the TG13 12 integrates the diagnostic modalities for AC, they are derived by expert opinion based on retrospective multicenter analysis and validated in the same population as the derivation cohort may limit the generalizability to other patient populations. We decided to develop a similar integrated approach to diagnosing AC but utilizing a systematic review/meta-analytic approach. The primary objective of this systematic review is to determine the diagnostic test accuracy (sensitivity, specificity, and likelihood ratios [LRs] ) of H&P, laboratory data, and imaging studies to predict AC for ED patients. Specifically, we were interested in finding elements of the H&P, laboratory data, and imaging studies available to ED physicians at the point of care, which would allow expedited disposition of patients suspected of AC without utilizing radiology department resources (US, CT, MRI, or HIDA). We limited our population to ED patients suspected of AC and specifically limited sonography as performed and interpreted by ED physicians. While there are several variants of AC, this study does not address variants such as emphysematous cholecystitis or acalculous cholecystitis, as they would require formal radiologic evaluation for diagnoses and therefore beyond the scope of point-of-care US (POCUS).
METHODS

Study Design
We conducted a systematic review of studies that examined the operating test characteristics of the modalities used by emergency physicians to diagnose AC. The systematic review was conducting using the Preferred Reporting Items for Systematic Review and Meta-analyses (PRISMA) guidelines. 13 
Search Strategy
The design and manuscript structure of this systematic review conform to the recommendations from the Meta-analysis of Observational Studies in Epidemiology (MOOSE) 14 statement. In conjunction with a medical librarian, six investigators independently searched the medical literature from January 1965 to March 2016 in PubMed, Embase, and SCOPUS for the search terms diagnosis and cholecystitis. Diagnosis was searched under MeSH headings diagnosis, diagnosis-related groups, delayed diagnosis, computer-assisted diagnosis, early diagnosis, differential diagnosis, immunologic tests, ultrasonography, laboratory techniques and procedures, or radiography. Cholecystitis was searched under MeSH headings blood, diagnosis, epidemiology, etiology, history, microbiology, pathology, physiology, physiopathology, radiography, ultrasonography, and cholecystitis. The two searches were combined and limited by human subjects, adults, and English language articles. The PubMed, Embase, and SCOPUS searches were combined for the three separate search topics: H&P, laboratory data, and US. Studies were included if they recruited adult patients in the ED who had a bedside emergency US. Studies were included only if the patient had the criterion standard for final diagnosis, which was predetermined to be pathology diagnosis or biliary scintography. Narrative reviews, case reports, or studies focused on children or therapy were not included.
Criteria for Considering Studies for This Review Types of Participants. We included studies that recruited adult patients presenting to the ED with abdominal pain or RUQ pain as their chief complaint. Studies that recruited patients who presented to an urgent care setting were excluded, as these patients are substantively different than those who present to the ED with true, emergent abdominal pain. Patients were not excluded based on comorbidities.
Types of Index Tests. We included studies that used H&P findings, laboratory tests, and US as index tests for the diagnosis of AC. We only included abdominal sonographic studies if performed and interpreted by ED physicians. While many EDs continue to order formal USs, there is a growing number of emergency physicians who are US trained and rely solely on POCUS. Additionally, RUQ US is a core emergency US application per ACEP 15 guidelines. As a result, many emergency physicians do in fact make the diagnosis of AC based on POCUS. Some institutions may continue to utilize formal US for a variety of other reasons. Nevertheless, there is a substantial amount of evidence that has shown POCUS to be just as sensitive and specific as formal US for diagnosis of AC.
16À19 For this reason, formal US was excluded from the analysis.
Types of Reference Standard. We included studies that used as a reference standard a final diagnosis of AC based on pathologic finding of AC at surgery or a positive biliary scintigraphy study.
Data Abstraction
Two or more authors for each index test category independently selected articles from the combined PubMed/Embase search for full text review (H&P = 734; laboratory data = 74; US = 492). Each reviewer independently selected potentially eligible studies before both authors agreed on the list of studies for full text review. Differences in study selection were resolved by consensus. Having read the methods sections of the full-text version of the studies potentially eligible for inclusion, each author then applied the stated inclusion and exclusion criteria to determine which studies to include in our systematic review. Differences were resolved by consensus after discussion and adjudication.
Data Analysis
Sensitivities, specificities, and LRs were calculated based on constructed two-by-two tables for each included study. To compute meta-analysis summary estimates when more than one study assessed the same index test, we combined test characteristic data using a random-effects model with Meta-DiSc software. 20 Interstudy heterogeneity was assessed for pooled estimates of sensitivity and specificity using the DerSimonian-Laird random-effect model. 21 Publication bias was not assessed because of the questionable validity of this approach in diagnostic meta-analyses. 22 Quality Assessment Two authors (NM, MS) used the Quality Assessment Tool for Diagnostic Accuracy Studies (QUADAS-2) 23 for systematic reviews to evaluate the overall quality of evidence for the trials included. For the purposes of this diagnostic systematic review, several considerations were established a priori to assess the quality of individual trials. The ideal patient population would be those presenting to an ED with abdominal complaints as mentioned.
The QUADAS-2 method assesses four categories of study design, including patient selection, index test, reference standard, and flow and timing. Four domains were assessed for biases. 1) Patient selection-Were the patients enrolled at random or consecutively? Were there inappropriate exclusions? Could the patients included not be representative of all patients presenting to the ED with a clinical picture of AC? 2) Index test-Was the history and physical examination obtained without knowledge of the results of criterion standard test for AC? Were thresholds for vital signs pre-determined for the study? Is there concern that the way the history and physical were obtained would be different than done in clinical practice? 3) Reference standard-Was the criterion standard test for AC obtained on every patient in the study? Were the radiologists blinded to the clinical findings? 4) Flow and timing-Could the order of how the history and physical and criterion standard test for AC were obtained and read have introduced bias? Studies would be considered low risk of bias if all four domains were rated no bias. All included studies used pathology as the reference standard, but if the reference standard was not clearly defined that portion of QUADAS-2 was at high risk for bias. Similarly, if execution of the index test was not clearly defined, that portion of QUADAS-2 would also be at high risk for bias. Each category is accompanied by a set of yes or no questions and answering no to any question places that portion of the study design at high risk for bias. An unweighted Cohen's kappa was calculated to measure agreement. Statistical agreement between these two reviewers was assessed via a kappa analysis using SPSS (v21.0). Two of the authors (NM and MS) individually rated the QUADAS-2 assessment with a kappa of 0.87. A meeting was held between the two QUADAS-2 raters and the third author (RS) who adjudicated any differences in QUADAS-2 rating.
Test-Treatment Threshold
The Pauker and Kassirer decision threshold model was used to develop a treatment algorithm. 24 This method is based on considering six variables: falsenegative and false-positive proportions, sensitivity, specificity, risk of a diagnostic test, risk of treatment, and anticipated benefit of treatment. Estimates of these variables were abstracted from our systematic review to derive theoretical test and treatment thresholds for ED patients with AC diagnosed via bedside emergency US (Figure 2 ).
RESULTS
Description of Included Studies
The PubMed, Embase, and SCOPUS search identified 734 citations for H&P (see Figure 1A ). For laboratory studies, PubMed, Embase, and SCOPUS identified a total of 74 articles (see Figure 1B ). For US, PubMed, Embase, and SCOPUS search identified a total of 492 articles (see Figure 1C) . Reviewing the bibliographies of the pertinent articles identified no additional studies. We excluded all studies of emphysematous and acalculous cholecystitis, which are present with an indefinable risk factor such as multisystem trauma, burns, chronic debilitation, total parenteral feeding, or immunosuppression, not typical of usual ED presentation of AC.
We decided to remove all the retrospective studies 5-7,25,26 from our review. Although, the work by Lijmer et al. 27 has shown that retrospective compared to prospective diagnostic studies, when corrected for methodologic flaws, do not produce different results, our retrospective studies all had significant flaws. All of our retrospective studies [5] [6] [7] 25, 26 had issues related to reliability of their retrospectively abstracted data. Gilbert et al. 28 has defined eight criteria: 1) training, 2) case selection, 3) definition of variables, 4) abstraction forms, 5) meetings, 6) monitoring, 7) blinding and 8) testing of inter-rater agreement of retrospective chart reviews to improve accuracy and minimize inconsistencies in data acquisition. All of our retrospective studies [5] [6] [7] 25, 26 failed to document any of these methods to assure unbiased data collection from their medical records. For these reasons, all retrospective studies were excluded from the final data analysis.
As detailed in Figure 1A (H&P, n = 3), Figure 1B (laboratory studies, n = 1), and Figure 1C (US (n = 4), a total of nine diagnostic studies were included in our final analysis, respectively. A full description of the reviewed studies, including the study design, subject characteristics, variables assessed, criterion standard, and AC prevalence is included in the tables for each diagnostic modality: H&P (Table 1A) , laboratory studies (Table 1B) , and US (Table 1C) .
Prevalence
The combined population from the eight unique cohorts included in this review was 1,990, of which 297 patients were diagnosed with AC. The weighted prevalence of AC across all studies was 14.9% with a range of 7% to 64%. Our reviewed studies using RUQ pain or suspected AC (seven studies, 8, 10, [29] [30] [31] [32] [33] [34] n = 657 patients) as their primary inclusion criteria and a higher prevalence of AC of 31% (range = 10%-64%) versus 7% (range = 7%-46%) compared to those with abdominal pain (Eskelinen et al., 35 n = 1,333 patients) as their primary inclusion criteria. This clearly suggests a selection bias for AC in those studies using RUQ pain 10, 29, 30, 32 or suspected AC compared to studies including all generalized abdominal pain 8, 31, [33] [34] [35] as their inclusion criteria.
H&P
All of the three studies 29, 30, 35 reviewed in the H&P section used a prospective observational methodology. Inclusion criteria were not uniform across our reviewed studies. Acute abdominal pain was the inclusion criteria for Eskelinen et al., 35 where Schofield et al. 29 and Bednarz et al. 30 included only those This difference in inclusion criteria explains the significantly higher AC prevalence (64 and 39%) in the latter two studies compared to Eskelinen et al. 35 (7%). Sample size also varied considerably between Bednarz et al. 30 (n = 70) and Eskelinen et al. 35 (n = 1,333). Ages of included patient ranged from means of 38 8 to 56 30 yrs. All studies showed a female preponderance of subjects from 50% in Bednarz et al. 30 to Schofield et al. 29 with 70%. • Acute abdominal pain • Less than 7 days' duration Exclusion:
• Not stated Of the H&P variables in Table 1A , an elevated temperature (37.1-38.°C) or "fever" was the most common AC sign reported in all of reviewed studies. All of our reviewed studies also contained "mass" as an assessed variable. RUQ pain, tenderness, and rebound were evaluated only by Bednarz et al. 30 and Eskelinen et al. 35 Only Bednarz et al. 30 tested jaundice while vomiting was only investigated by Schofield et al. 29 Studies by Schofield et al. 29 and Eskelinen et al. 35 used the finding of gallstones at surgery as their criterion standard for AC, and the study by Bednarz et al. 30 used both gallstones at surgery (79%) as well as clinical definition (29%).
Test Characteristics of H&P for AC
From Table 2A , we found that the effects of only two to three studies per risk factor coupled with the differences in study populations between generalized abdominal pain and RUQ pain resulted in such marked heterogeneity; that pooling of the data was not adequate. We decided to report only point estimates and not pooled data for any of our test characteristics. We grouped the variable fever for the three reviewed studies together even though the study by Bednarz et al. 30 did not specify a specific temperature and the other two studies reported very similar cutoffs of >37.5°C 29 and >37.1°C. 35 We found that fever had very poor test characteristics with sensitivities between 31% 29 and 62%, 35 specificities of 37% 30 to 74%, 29 positive LR (LR+) of 0.71 30 to 1.24, 35 and negative LR (LR-) of 0.76 35 to 1.49. 30 Between the Bednarz et al. 30 and Eskelinen et al. 35 studies, marked heterogeneity was noted for the variables RUQ pain, mass, and tenderness, most likely secondary to biases documented in our QUADAS-2 analysis. Even with these biases none of characteristics of RUQ mass, pain, or tenderness or the other risks such as RUQ rebound, jaundice, Murphy's sign, or vomiting had sufficiently low LR-'s to significantly decrease the probability of AC.
QUADAS-2 Analysis for H&P for AC All of our reviewers agreed 100% on the QUADAS-2 scoring for the three H&P studies we reviewed (Table  3 ). All reviewers found all three studies to have high risks of bias in reporting H&P test characteristics. The study by Eskelinen et al. 35 suffered from differential verification bias. Differential verification bias, also called double criterion standard bias, as described by Kohn et al., 36 occurs when the results of the index test determine different gold standards. Since the study by Eskelinen et al. 35 was a study of all patients with abdominal pain, those patients who tested positive for any of the index tests commonly associated with AC such as RUQ findings (mass, pain, tenderness), jaundice, or Murphy's sign were all preferentially tested for the criterion standard for AC. Those patients without any of these signs of AC were then tested for other differential diagnoses of acute abdominal pain, utilizing different criterion standard tests. Only 10.1% of the study population of Eskelinen et al. 35 had AC, while 30.2% had acute appendicitis with 40% diagnosed as nonspecific abdominal pain with remainder having nephrolithiasis, dyspepsia, small bowel obstruction, and other less common etiologies of abdominal pain. Differential verification bias in the case of the study by Eskelinen et al. 35 significantly falsely raised the specificity to greater than 95% for RUQ (mass, pain, tenderness), jaundice, and Murphy's sign, with a smaller effect on sensitivity with result of inflating the LR+ (>13) for all these test characteristics.
When we examine the test characteristic of RUQ pain in Table 2A , we see an excellent example of partial verification bias in the study of Bednarz et al. 30 Also as described by Kohn et al. 36 partial verification bias, verification bias, referral, ascertainment, or workup bias occurs when patients positive for the 30 This causes the sensitivity to be falsely raised (93%) while deceptively depressing the specificity (0%).
Laboratory Findings
Only the study by Eikman et al. 8 all met our inclusion criteria for review in the laboratory findings section in Table 1B . Studies by Brewer et al. 31 and Potts et al. 7 were both retrospective studies and were excluded from our review for the already stated reason for failure to abide by the quality criteria established by Gilbert et al. 28 In addition, the study by Potts et al. 7 only enrolled patients > 80 years old, significantly limiting the generalizability of their observations. Eikman et al. 8 included patients with abdominal pain suspected of AC and were tested by hepatobiliary scintigraphy. Although the main focus of the study Eikman et al. 8 was hepatobiliary scintigraphy, with sufficient data on AC to permit evaluation of the test characteristic of total bilirubin. Eikman et al. 8 defined their criterion standard by the presence of gallstones at surgery, with a AC prevalence of 26%.
Test Characteristics of Laboratory Findings for AC
From Table 2B , we only report single study test characteristics for total bilirubin from the study by Eikman • Not stated Image interpretation:
• As above Surgical pathology 37 (22-56) EP = emergency physician; RDMS = registered diagnostic medical sonographer; RUQ = right upper quadrant; US = ultrasound.
et al. 8 The presence of an elevated bilirubin not surprisingly increased (LR+ = 5.80) the probability of AC. Elevated bilirubin was defined as greater than 2.0 mg/100 mL. Total bilirubin was not sufficiently robust to significantly decrease (LR-= 0.64) the probability of AC.
QUADAS-2 Analysis for Laboratory Findings for AC
All of our reviewers agreed 100% on the QUADAS-2 scoring for the single laboratory study we reviewed (Table 3B ). All reviewers found the study by Eikman et al. 8 to have high risks of bias secondary to partial verification bias. Since the study by Eikman et al. 8 included only those patients suspected of AC, the index test (an elevated total bilirubin) we chose to review was probably used as an inclusion criterion defining at least a subset of patients suspected of AC. If the index test increased the probability of patients chosen to receive the diagnostic test (hepatobiliary scintigraphy) then the study is at risk for partial verification bias. As was the case in the study by Bednarz 30 in the H&P group who used RUQ pain as both an index test of AC and a study inclusion criterion.
ED Bedside US
Four studies, by Kendall and Shimp, 32 Rosen et al., 33 Summers et al., 10 and Noble et al., 34 met our final inclusion criteria for review. Blaivas and Adhikari 9 was removed from final analysis due to concerns of potential biases related to data entry as per the requirements set forth by Gilbert et al. 28 Villar et al. 37 used the same data set as Summers et al. 10 and therefore was excluded from the final reviewed studies. Jang et al. 19 was excluded due to significant overlap of data point and lack of reproducibility of the data. Studies by Schlager et al. 38 and Jehle et al. 39 were both The experience of the ED sonographers varied greatly across the studies. Only Kendall and Shimp 32 detailed the training of the ED sonographers used for their study. Rosen et al. 33 documented that at least 48% of their ED sonographers in their study had greater than 25 previous RUQ USs before the study. The studies by Summers et al. 10 and Noble et al. 34 failed to document the experience of their ED sonographers. All studies used the same sonographer to both acquire and interpret their studies. None of the studies utilized overreads by more experienced ED ultrasonographers or radiologists. None of the studies reported intra-or inter-rater reliability of their ED or radiology USs.
Test Characteristics of ED Bedside Sonography for AC
Marked heterogeneity (chi-square p > 0.05, I 2 = 75%) between the test characteristics precluded us from reporting pooled results. From Table 2C , we noted a range of sensitivity for AC between (82%-91%), specificity (66%-95%), LR+ (2.68-15.55), and LR-(0.13-0.21). The study by Noble et al. 34 provided for a substantial degree of heterogeneity between test characteristics for sonography. Although Noble et al. 34 used RUQ pain similar to the other reviewed studies, the primary hypothesis of this study was not the operating characteristics of sonography, but was a comparison of the sonographic Murphy sign (SMS) before and after analgesia. Since Noble et al. 34 only studied SMS and not the whole range of the sonographic findings (wall thickening, pericholecystic fluid, sludge, etc.) associated with AC, it is not surprising their test characteristics are outliers. A sensitivity analysis of the operating characteristics after removing the Nobel et al. 34 still showed significant heterogeneity for specificity (chisquare p = 0.20, I 2 = 74%; range = 66%-84%) and LR+ (chi-square p = 0.24, I 2 = 73%; range = 2.7-5.4). After excluding Nobel et al., 34 heterogeneity for sensitivity and LR-significantly decreased allowing pooling of sensitivity (chi-squared p = 0.67, I 2 = 0%; pooled = 88%; range = 75%-95%) and LR-(chisquare p = 0.84, I 2 = 0%; pooled = 0.16; range = 0.08-0.31).
QUADAS-2 Analysis for ED Bedside
Sonography for AC All of our reviewers agreed 100% on the QUADAS-2 scoring for the four ED US studies we reviewed (Table  3C ). The study by Summers et al. 10 may also have been influenced by partial verification bias, in that 189 ED USs were studied but only 125 of these patients were referred to radiology US. In the study by Summers et al. 10 the results of the index test (ED US) partially determined workup (radiology US; partial verification bias). Of the 189 ED US examinations, 26 went to the operating room (24 positive for AC) and 163 were discharged to telephone follow up, of whom 23 patients were unable to be contacted. Since we do not know the prevalence of AC in the patients lost to follow-up, the potential exists for follow-up bias. Partial verification bias may have also affected the study by Noble et al., 34 which only examined SMS, so positive SMS patients may have been preferentially referred to radiology US.
In the study by Rosen et al., 33 of the 116 patients enrolled in the ED US study, 40 (34%) were excluded from further analysis if the ED US had discordant results either positive for gallstones and a negative SMS or vice versa. Since the results of the index test partially determined the etiology of findings requiring a continued workup, this study also was exposed to partial verification bias. Partial verification was not an issue with the study by and Kendall and Shimp 32 as it appears that all patients in both studies who received a ED US also received a radiology US.
Test-Treatment Threshold Estimates
The test-treatment threshold model we developed was designed to aid physicians in efficiently and accurately ruling in or ruling out the diagnosis AC. We built this model to investigate which element(s) of the H&P, laboratory findings, and ED US had sufficient discriminatory power given the pretest probability of AC to obviate a formal test by radiology: an official US, MRI, or HIDA scan. Given that these formal radiology department tests are not available 24 hours per day, 7 days a week, if element(s) of the H&P, laboratory studies, or ED US were sufficiently robust to rule in or rule out AC, patient disposition to either discharge or begin empiric AC therapy would be facilitated.
In Figure 2 , we created three test-treatment threshold models (1, radiology US; 2, MRI; and 3, HIDA) to diagnose AC. The top half of the Figure 2 describes the variables and calculations used to produce the test and treatment thresholds depicted in graphic below for each the three formal diagnostic tests (1, radiology US; 2, MRI; 3, HIDA) for AC. For each diagnostic modality a separate set of test and treatment thresholds were defined across a range 0% to 100%. Based on the work of Pauker and Kassirer 24 these three models utilized the unique operating characteristics of each diagnostic modality while controlling for the risks of treatment of patients without AC (Rrx), the risk of the diagnostic test (Rt), and the benefit of treatment with AC (Brx).
For each diagnostic modality we used individual operating characteristics coupled with the variables Rrx, Rt, and Brx to develop unique test-treatment thresholds. Since the operating characteristics for the three diagnostic modalities differ, their test-treatment thresholds also vary.
The test thresholds are depicted as the left-most open arrow for each diagnostic modality (radiology US and MRI 4%, nuclear 2%). If the posttest probability of the index test we choose from our systematic review (dashed vertical line) falls to the left the test-threshold than further testing for AC is not warranted and an alternative diagnosis other than AC should be considered. The treatment thresholds are represented by the right-most open arrow for each diagnostic modality (radiology US 46%, MRI 52%, HIDA 74%). When the posttest probability of the index test is to the right of the treatment threshold, further testing is unnecessary and treatment should be initiated based only on the results of the index test. If the posttest probability of the index test falls between the test and treatment thresholds, then our analysis recommends continued testing with that diagnostic modality for AC. The horizontal dashed lines represent the ranges of posttest probabilities of a positive or negative ED US consistent with AC.
Our three models for the test-treatment thresholds for diagnosing/treating AC are based on the individual operating characteristics of radiology US, MRI, and nuclear that were recently documented in a systematic review by Kiewiet et al. 40 They reviewed 57 studies encompassing 5,859 patients and found HIDA with the highest sensitivity (94%) and specificity (90%), followed by MRI sensitivity (86%) and specificity (82%) and radiology US sensitivity (82%)/specificity (81%).
The definitive treatment, i.e., operative management, is always delayed while obtaining these radiology-based studies and delayed further during off-hours when these tests are not routinely available. While AC is an inflammatory process, secondary infection can occur due to cystic duct obstruction and bile stasis, leading to gangrene, sepsis, and gallbladder perforation. 1, 2, [5] [6] [7] 41, 42 The possibility of coexistent bacterial infection in AC is the justification for starting empiric antibiotics especially if delays of definitive diagnosis and surgical management are expected. Empiric antibiotic therapy should include activity against the most frequently associated pathogens: Escherichia coli, Enterococcus, and Klebsiella. 41 We defined the risks of treatment without disease (Rrx) as the risks of antibiotics for presumed AC whom after radiology-based tests rules out AC. Patients without AC but exposed to antibiotics would suffer all the risks of antibiotics without any of their intended benefits. We will define (Rrx) as the overall risk of adverse drug reaction is 16.8%. 42 We judged the risk of the diagnostic tests (Rt) US, MRI, and HIDA as zero. Finally, the benefit of treatment (Brx) of patients with AC has never been, nor ever will be, tested by a randomized double-blinded placebo controlled methodology; it would be unethical to study the spontaneous recovery rate of AC without antibiotics or surgery. Without evidence-based studies we used a conservative estimate of the benefit from treating AC (Brx) = 0.90.
Of the H&P, laboratory, and US characteristics in this review, only ED US resulted in a significant change in LR of positive test ranged from (LR+ = 2.68-4.72) or a negative US (LR-= 0.13-0.21) after excluding Noble et al., 34 for reasons explained. We defined the pretest probability of AC by the weighted prevalence (31%) across the reviewed studies of using RUQ as entry criteria. Applying Bayes theorem of a pretest probability of AC = 31% with LR+ of 2.68-4.72 and LR-of 0.13-0.21 would lead to a range of posttest probabilities after a positive ED US for AC (55%-68%) or a negative US (6%-7%).
In Figure 2 , in the case of a negative ED US for AC the posttest probability would only decrease from 31% to 6%-7%; our analysis would recommend further testing for all three diagnostic modalities (test thresholds: radiology US = 4%, MRI = 4%, and HIDA = 2%). Thus, a negative ED US is not sufficient to adequately rule out AC and continued testing is required before discharge of a patient suspected of AC. If the ED US is positive for AC, the posttest probability of AC would increase from 31% to 55%-68% and obviate further testing for the diagnostic modalities of radiology US (treatment threshold = 46%) and MRI (treatment threshold = 52%). The nuclear scan model, because of higher sensitivity (90%) and specificity (94%) compared to the other two modalities, recommends further testing (treatment threshold = 74%) even if the ED US was positive for AC.
DISCUSSION
This systematic review examines the utility of H&P, laboratory studies, and ED US for the diagnosis of AC in the ED population. We found eight studies that met inclusion criteria for H&P (n = 3), for laboratory studies (n = 1), and for ED US (n = 5) with varying quality based on the degree of bias.
Similar to the findings by the rational clinical examination of Trowbridge et al., 43 "Does This Patient Have Acute Cholecystitis?" we found with an updated search that no single H&P finding or laboratory test was sufficiently robust to rule out AC. This is not to suggest that H&P and laboratory findings are of no utility in the diagnosis of AC, as the presence of these variables is necessary to define the at-risk population in the first place. Ross et al. 18 compared ED US to other modalities if imaging for cholelithiasis; however, H&P and laboratory were not included in the primary review.
Observational studies of AC patients from Cope's Early Diagnosis of the Acute Abdomen 44 in 1921 to the most recent (2013) update of the Tokyo AC guidelines 12 help us form our clinical gestalt of an AC patient. Unfortunately, these observational studies by their very nature suffer from verification bias, severely limiting their potential to find characteristics of patients suspected of AC, which can substantially rule out AC. While the index tests for AC (RUQ pain/ mass/tenderness/Murphy's sign/fever/WBC) are very common in AC patients, we only understand their true clinical utility when we examine the prevalence of AC in patients without these cardinal signs of AC. In our study, LR-for H&P ranged from 0.26 to 7.86, and LR-for an elevated WBC was 0.64, meaning that we were not able to use any of these findings to significantly decrease the posttest probability of AC and obviate further formal radiology testing.
From our ED US studies reviewed we were able to find studies with LRs (LR+'s of 2.68 to 4.72) and (LR-'s of 0.13 to 0.21) significantly robust enough to produce marked changes from pre-to posttest probabilities of AC. In comparing the performances of radiology to ED US, our reviewed studies found disparate results. Summers et al. 10 found no significant differences in the operating characteristics of formal radiology US (LR+ = 5. 33 only found a kappa of 0.46 for the AC agreement of ED and formal radiology US. Kendall and Shimp 32 only directly compared the ED US to formal radiology US for the detection of SMS and found the ED US (sensitivity = 82%) greater than the formal US (45%). Some of this heterogeneity in comparing the accuracy between radiology and ED US can be ascribed to the variations in the sonographic experience across the various studies. In addition, none of these studies included tests of inter-rater or intra-rater reliability of the ED sonographers.
Using our test-treatment threshold estimates (Figure 2) with a pretest probability of AC (weighted AC prevalence) of 31% and a positive ED US for AC an ED physician could initiate empiric AC antibiotics and a surgery consultation obtained for admission, without the need for formal radiology department testing with US or MRI scans. A negative ED US would only decrease the posttest AC probability to 6%-7%, still just above the testing threshold (US and MRI 4%, HIDA 2%) for the three formal diagnostic modalities. The decision not to go onto further formal AC testing will be a clinical decision based on your own clinical judgment of either accepting a miss rate of AC between 6 and 7% or applying a lower pretest probability of AC than 31% maybe commensurate with your clinical experience. A change in the estimate of the pretest probability of AC to 25% would place a negative ED US posttest probability of AC (4%) at the cutoff for the test threshold for both radiology US and MRI (4%). If the pretest probability is as low as 15%, then a negative ED US could hit the lower limit of the test threshold (2%) for even the HIDA scan. On the other hand, considering that ED US and radiology US are equally accurate, as described, since the posttest probability of an ED US is 6%-7% and the testtreatment threshold for all three modalities are 4%, the difference between 6 and 4% is insignificant enough to obviate further testing as per clinical judgment, especially in the absence of an elevated bilirubin. In this case, perhaps an alternate diagnosis should be pursued.
With an increasing movement toward early intervention for patients with AC, the utility of ED US for early diagnosis will aid to avoid unnecessary delay in intervention, as well as reduction of outpatient referrals and repeated ED visits, which overall is more cost-effective and improve patient suffering and experience. 45 Implications for Future Research Characteristics of disease have not been studied in the current era. Lifestyles and food habits have changed in the past 40 years. All of studies in the H&P and laboratory section were done before 2000. None of the studies evaluated the discriminatory power of different historical, physical examination, and laboratory findings in combination. High-quality diagnostic studies of AC in the future should combine H&P, laboratory data, and ED US with specific concerns for limiting bias and directly measuring the efficiencies obtained by ED POCUS, that is, the decreased time to achieve diagnosis. The outcome test should not be based on the index test. Additionally, future studies should report inter-rater reliability of the ED US interpretations given that US is a user-dependent modality. Combining features may lead to better operating characteristics and should be considered in future studies.
LIMITATIONS
Only three databases, PubMed, Embase, and SCOPUS, were used. Also notable is the paucity of H&P and laboratory studies. Despite a 4:1 female predisposition to AC, only one study by Irvin et al. 3 examined this parameter. These studies did not include other factors that predispose patients to AC, i.e., race and diabetes. When examining many other parameters included in this study, there are few studies per parameter. For example, Singer et al. 25 is the only study that met inclusion criteria and took history of gallstones into account. Furthermore, these studies are over 20 years old and may no longer represent current lifestyles and risk factors.
The diagnostic tools are associated with limitations as well. While the risk of diagnostic tests such as US, MRI, and HIDA are estimated as zero, these tests do have some quantifiable risk. MRI and HIDA require patients to leave the ED, which holds some risk as well. While not a direct or immediate risk, oftentimes imaging studies find results not expected with current investigation purposes; these "incidentalomas" may lead to further testing and expose patients to further risk.
Ultrasound is a user-dependent modality. Many studies that include USs as diagnostic criteria include USs predominantly performed by emergency physicians who are very experienced and motivated to perform ultrasonography. This does not represent actual practice where bedside US is performed by the practitioner caring for the patient, who may or may not be a registered sonographer.
CONCLUSION
Right upper quadrant complaints are a frequently encountered complaint among ED visits. The decision to pursue and treat these complaints is multifactorial. The primary objective of this systematic review is to assess variables of history and physical examination, laboratory testing, and ultrasound impact on making the diagnosis of acute cholecystitis. We found that there is no one parameter that would suggest an immediate cause to treat and pursue surgical intervention. Individually, the many variations of complaints as well as clinical findings do not reliably rule out acute cholecystitis, thereby necessitating a clinical decision rule to include multiple parameters (history and physical, laboratory data, and sonographic imaging) to achieve a correct diagnosis of acute cholecystitis.
